Health watchdog to restrict use of similar tradename over renewal product

Published: 2009-02-11 07:00:00

Updated: 2009-02-11 07:00:00

The Korea Food and Drug Administration says it will not allow drugmakers to use any brand name by adding letter(s), word(s) or figure(s) to the already licensed medicine, citing a case that it rejected the use of Huon’s Salsalazine, a popular herbal medicine for treatment of obesity, to its dose-...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK